Development of a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders: Study protocol for the naltrexone neuroimaging randomized controlled trial (NN-RCT)
Stephani L. Stancil(Children's Mercy Hospital), Laura E. Martin(University of Kansas Medical Center), Ann M. Davis(Seattle Children's Hospital), Michaela Voss(University of Missouri–Kansas City), William M. Brooks(University of Kansas Medical Center), Anna Burns(Children's Mercy Hospital), Morgan G. Brucks(University of Kansas Medical Center), James Bartolotti(University of Kansas Medical Center), John Tumberger(Children's Mercy Hospital), Hung‐Wen Yeh(Children's Mercy Hospital), Mariah Brewe(Children's Mercy Hospital), Susan M. Abdel‐Rahman(Children's Mercy Hospital), Michael Bartkoski(Children's Mercy Hospital), Jeffrey R. Strawn(Cincinnati Children's Hospital Medical Center)
Cited by 1
Related Papers
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
|Breast Cancer Research|2009|298
Assessment and Treatment of Anxiety Disorders in Children and Adolescents
|Current Psychiatry Reports|2015|291
A Nonlinear Simulation Framework Supports Adjusting for Age When Analyzing BrainAGE
|Frontiers in Aging Neuroscience|2018|285
Consensus features nested cross-validation
|Bioinformatics|2020|224
Magnetic Resonance Imaging and Brain Histopathology in Neuropsychiatric Systemic Lupus Erythematosus
|Seminars in Arthritis and Rheumatism|2009|168